Adage Capital Partners
STML

Adage Capital Partners’s Stemline Therapeutics, Inc. STML Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,068,829
Closed -$14.9M 824
2020
Q1
$14.9M Sell
3,068,829
-141,171
-4% -$683K 0.04% 389
2019
Q4
$34.1M Sell
3,210,000
-1,190,000
-27% -$12.6M 0.08% 276
2019
Q3
$45.8M Buy
4,400,000
+400,000
+10% +$4.16M 0.11% 214
2019
Q2
$61.3M Buy
4,000,000
+500,000
+14% +$7.66M 0.15% 172
2019
Q1
$45M Buy
3,500,000
+2,789,986
+393% +$35.9M 0.11% 214
2018
Q4
$6.75M Hold
710,014
0.02% 571
2018
Q3
$11.8M Sell
710,014
-450,000
-39% -$7.47M 0.03% 525
2018
Q2
$18.6M Sell
1,160,014
-632,043
-35% -$10.1M 0.04% 417
2018
Q1
$27.4M Buy
1,792,057
+357,143
+25% +$5.46M 0.06% 330
2017
Q4
$22.4M Buy
1,434,914
+777,556
+118% +$12.1M 0.05% 381
2017
Q3
$7.3M Buy
+657,358
New +$7.3M 0.02% 596